Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-141-3 | CAS number: 10043-67-1
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: peer-reviewed reports from EPA and OECD
Data source
Referenceopen allclose all
- Reference Type:
- secondary source
- Title:
- HUMAN HEALTH AND ECOLOGICAL HAZARDS SUMMARY
- Author:
- United States Environmental Protection Agency (US EPA)
- Bibliographic source:
- HUMAN HEALTH AND ECOLOGICAL HAZARDS SUMMARY
- Reference Type:
- secondary source
- Title:
- SIDS Dossier Potassium Sulfate
- Author:
- OECD
- Year:
- 2 007
- Bibliographic source:
- OECD HPV Chemical Programme, SIDS Dossier, approved at SIAM 25 (16-19 October, 2007)
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Deviations:
- not specified
- Principles of method if other than guideline:
- no data available
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Potassium sulfate
- EC Number:
- 231-915-5
- EC Name:
- Potassium sulfate
- Cas Number:
- 7778-80-5
- Molecular formula:
- H2O4S.2K
- IUPAC Name:
- dipotassium sulfate
Constituent 1
Results and discussion
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): no bioaccumulation potential based on study resultsAbsorption of potassium sulfate is expected to be nil through the skin and good through the lungs and GI tract. No significant adverse effects from potassium sulfate representing parts of the ionic inorganic components of aluminium potassium bis sulphate are to be expected. After absorption and distribution potassium and sulfate should be complete excreted through urine and feces.The read across substance potassium sulfate is an inorganic salt with high aqueous solubilityand will exist in a dissociated form in solution and, thus will not bioaccumulate. .Therefore potassium sulfate representing parts of ionic inorganic components of aluminium potassium bis sulphate should have no relevant bioaccumulation potential.
- Executive summary:
Absorption of potassium sulfate is expected to be nil through the skin and good through the lungs and GI tract.
No significant adverse effects from potassium sulfate representing parts of the inorganic components
of aluminium potassium bis sulphate are to be expected.
After absorption and distribution potassium and sulfate should be complete excreted through urine and feces.
Therefore potassium sulfate representing parts of ionic inorganic components of aluminium potassium bis sulphate
should have no relevant bioaccumulation potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
